Connect Biopharma Holdings Ltd - ADR Forecast, price target & analysts
Connect Biopharma Holdings Ltd - ADR Target price 2026 - Analyst rating & recommendation
Connect Biopharma Holdings Ltd - ADR Classifications & Recommendation
Connect Biopharma Holdings Ltd - ADR Price Target
| Target Price | $7.14 |
| Price | $1.08 |
| Potential |
561.11%
register free of charge
|
| Number of Estimates | 10 |
|
10 Analysts have issued a price target Connect Biopharma Holdings Ltd - ADR 2027 .
The average Connect Biopharma Holdings Ltd - ADR target price is $7.14.
This is
561.11%
register free of charge
$10.50
872.22%
register free of charge
$4.04
274.07%
register free of charge
|
|
| A rating was issued by 14 analysts: 13 Analysts recommend Connect Biopharma Holdings Ltd - ADR to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Connect Biopharma Holdings Ltd - ADR stock has an average upside potential 2027 of
561.11%
register free of charge
|
Sales and Margin forecast 2026, 2027 to 2033
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million $ | 0.06 | 7.59 |
| 99.77% | 12,543.33% | |
| Net Margin | -92,466.67% | -896.43% |
| 153,892.79% | 99.03% |
10 Analysts have issued a sales forecast Connect Biopharma Holdings Ltd - ADR 2026 . The average Connect Biopharma Holdings Ltd - ADR sales estimate is
This results in the following potential growth metrics:
10 Connect Biopharma Holdings Ltd - ADR Analysts have issued a net profit forecast 2026. The average Connect Biopharma Holdings Ltd - ADR net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -1.00 | -1.08 |
| 257.14% | 8.00% | |
| P/E | negative | |
| EV/Sales | 4.81 |
10 Analysts have issued a Connect Biopharma Holdings Ltd - ADR forecast for earnings per share. The average Connect Biopharma Holdings Ltd - ADR EPS is
This results in the following potential growth metrics and future valuations:
Connect Biopharma Holdings Ltd - ADR...
Current Connect Biopharma Holdings Ltd - ADR Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Oppenheimer |
Locked
➜
Locked
|
Locked | Sep 22 2026 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Sep 17 2026 |
| Canaccord Genuity |
Locked
➜
Locked
|
Locked | Sep 16 2026 |
| BTIG |
Locked
➜
Locked
|
Locked | Sep 15 2026 |
| Oppenheimer |
Locked
➜
Locked
|
Locked | Jul 09 2026 |
| Piper Sandler |
Locked
➜
Locked
|
Locked | Jun 26 2026 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Jun 25 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
Oppenheimer:
Locked
➜
Locked
|
Sep 22 2026 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Sep 17 2026 |
|
Locked
Canaccord Genuity:
Locked
➜
Locked
|
Sep 16 2026 |
|
Locked
BTIG:
Locked
➜
Locked
|
Sep 15 2026 |
|
Locked
Oppenheimer:
Locked
➜
Locked
|
Jul 09 2026 |
|
Locked
Piper Sandler:
Locked
➜
Locked
|
Jun 26 2026 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Jun 25 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
